Amicogen, Inc. — Investor Relations & Filings
Amicogen, Inc. is an industrial biotechnology company specializing in the development and production of specialty enzymes and proteins. The company operates across three primary business areas: Enzyme and Biopharmaceuticals, Healthcare and Nutrition, and Bioprocess and CDMO (Contract Development and Manufacturing Organization) services. Leveraging its proprietary enzyme technology, Amicogen creates innovative solutions for the biopharmaceutical, food, and cosmetics industries. The healthcare division develops and manufactures functional food ingredients and nutritional products. The company also provides bioprocess solutions, including protein purification resins and comprehensive CDMO services to support the biopharmaceutical sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 분기보고서 (2026.03) | 2026-05-14 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-04 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2026-05-04 | Korean | |
| [기재정정]사업보고서 (2024.12) | 2026-04-30 | Korean | |
| [기재정정]분기보고서 (2025.03) | 2026-04-30 | Korean | |
| [기재정정]반기보고서 (2025.06) | 2026-04-30 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45879546 | 분기보고서 (2026.03) | 2026-05-14 | Korean | ||
| 40830949 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-04 | Korean | ||
| 40830871 | 주식등의대량보유상황보고서(일반) | 2026-05-04 | Korean | ||
| 39073552 | [기재정정]사업보고서 (2024.12) | 2026-04-30 | Korean | ||
| 39073409 | [기재정정]분기보고서 (2025.03) | 2026-04-30 | Korean | ||
| 39073184 | [기재정정]반기보고서 (2025.06) | 2026-04-30 | Korean | ||
| 39073033 | [기재정정]분기보고서 (2025.09) | 2026-04-30 | Korean | ||
| 39072792 | [기재정정]사업보고서 (2025.12) | 2026-04-30 | Korean | ||
| 39066980 | [기재정정]사업보고서 (2025.12) | 2026-04-30 | Korean | ||
| 37959259 | [기재정정]전환사채(해외전환사채포함)발행후만기전사채취득 (제5회차) | 2026-04-28 | Korean | ||
| 37939432 | [기재정정]전환사채(해외전환사채포함)발행후만기전사채취득 (제4회차) | 2026-04-28 | Korean | ||
| 37939311 | [기재정정]전환사채(해외전환사채포함)발행후만기전사채취득 (제5회차) | 2026-04-28 | Korean | ||
| 34568163 | 전환가액의조정 (제6회차) | 2026-04-15 | Korean | ||
| 33095696 | 정기주주총회결과 | 2026-03-31 | Korean | ||
| 33012316 | 사업보고서 (2025.12) | 2026-03-23 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Santhera Pharmaceuticals Holding AG
Develops and commercializes medicines for rare neuromuscula…
|
SANN | CH | Manufacturing |
|
Sarepta Therapeutics, Inc.
Biopharmaceutical company engineering genetic medicines for…
|
SRPT | US | Manufacturing |
|
SAREUM HOLDINGS PLC
Clinical-stage company developing kinase inhibitors for aut…
|
SAR | GB | Manufacturing |
|
SATTVA SUKUN LIFECARE LIMITED
Develops and manufactures generic medicines and diverse pha…
|
539519 | IN | Manufacturing |
|
Saudi Pharmaceutical Industries and Medical Appliances Corp.
Develops, manufactures, and distributes pharmaceuticals and…
|
2070 | SA | Manufacturing |
|
Savara Inc
A clinical-stage biopharmaceutical company developing thera…
|
SVRA | US | Manufacturing |
|
SAWAI GROUP HOLDINGS Co., Ltd.
Pharmaceutical holding company that develops and markets ge…
|
4887 | JP | Manufacturing |
|
Scienture Holdings, Inc.
Develops and distributes specialty products for central ner…
|
SCNX | US | Manufacturing |
|
Scilex Holding Co
Develops and commercializes non-opioid products for acute a…
|
SCLX | US | Manufacturing |
|
Scinai Immunotherapeutics Ltd.
A clinical-stage biopharma developing NanoAbs and providing…
|
SCNI | US | Manufacturing |
Amicogen, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16981/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16981 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16981 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16981 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16981}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Amicogen, Inc. (id: 16981)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.